Document is current
Any future updates will be listed below
-
Authors
Timm, Irina https://orcid.org/0000-0002-2957-242X
Giurgiu, Marco https://orcid.org/0000-0001-6684-3463
Ebner-Priemer, Ulrich
Reichert, Markus https://orcid.org/0000-0003-3290-0962
-
Funding
Funding for this research was provided by:
Karlsruher Institut für Technologie (KIT)
- License Information
-
More Information
Article History
Accepted: 1 March 2024
First Online: 6 May 2024
Declarations
:
: No funding was received.
: UWE-P reports consultancy for Boehringer-Ingelheim and speaker honorarium from Angelini Pharma. The authors declare that they have no competing interests.
: The data are available from the authors on request.
: Not applicable.
: Not applicable.
: MR and UWE-P conceived and designed the study. Material preparation, data collection, and analysis were performed by IT and MG. The first draft of the manuscript was written by IT and MR. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
